Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pollastri

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|October 26, 2011
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sicknessNicholas D Bland, Cuihua Wang, Craig Tallman, et al.
Plos Neglected Tropical Diseases|October 24, 2014
Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaignRosario Diaz, Sandra A Luengo-Arratta, João D Seixas, et al.
Plos Neglected Tropical Diseases|February 9, 2019
Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agentsDana M Klug, Rosario Diaz-Gonzalez, Guiomar Pérez-Moreno, et al.
Journal of Medicinal Chemistry|December 18, 2019
Selectivity and Physicochemical Optimization of Repurposed Pyrazolo[1,5-<i>b</i>]pyridazines for the Treatment of Human African TrypanosomiasisWestley F Tear, Seema Bag, Rosario Diaz-Gonzalez, et al.
ACS Infectious Diseases|July 7, 2023
Structure-Property Optimization of a Series of Imidazopyridines for Visceral LeishmaniasisMaria Dichiara, Quillon J Simpson, Antonio Quotadamo, et al.
Journal of Medicinal Chemistry|August 13, 2024
Pharmacophore Identification and Structure-Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of <i>Trypanosoma brucei</i>Lori Ferrins, Rosario Diaz, Carlos Cordon-Obras, et al.
Journal of Medicinal Chemistry|September 20, 2025
Optimization of Physicochemical Properties and ADME for 2,4-Substituted 1<i>H</i>-Pyrrolo[2,3<i>b</i>]pyridines Inhibitors of Trypanosome ProliferationKelly A Bachovchin, Rosario Díaz, Gloria Ceballos-Perez, et al.
Journal of Medicinal Chemistry|June 22, 2021
Lead Optimization of 3,5-Disubstituted-7-Azaindoles for the Treatment of Human African TrypanosomiasisDana M Klug, Eftychia M Mavrogiannaki, Katherine C Forbes, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Scaffold and Parasite Hopping: Discovery of New Protozoal Proliferation InhibitorsBaljinder Singh, Jean A Bernatchez, Laura-Isobel McCall, et al.
RSC Medicinal Chemistry|January 22, 2021
Structure-property studies of an imidazoquinoline chemotype with antitrypanosomal activityDana M Klug, Rosario Diaz-Gonzalez, Travis J DeLano, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|October 26, 2011
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sicknessNicholas D Bland, Cuihua Wang, Craig Tallman, et al.
Plos Neglected Tropical Diseases|October 24, 2014
Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaignRosario Diaz, Sandra A Luengo-Arratta, João D Seixas, et al.
Plos Neglected Tropical Diseases|February 9, 2019
Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agentsDana M Klug, Rosario Diaz-Gonzalez, Guiomar Pérez-Moreno, et al.
Journal of Medicinal Chemistry|December 18, 2019
Selectivity and Physicochemical Optimization of Repurposed Pyrazolo[1,5-<i>b</i>]pyridazines for the Treatment of Human African TrypanosomiasisWestley F Tear, Seema Bag, Rosario Diaz-Gonzalez, et al.
ACS Infectious Diseases|July 7, 2023
Structure-Property Optimization of a Series of Imidazopyridines for Visceral LeishmaniasisMaria Dichiara, Quillon J Simpson, Antonio Quotadamo, et al.
Journal of Medicinal Chemistry|August 13, 2024
Pharmacophore Identification and Structure-Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of <i>Trypanosoma brucei</i>Lori Ferrins, Rosario Diaz, Carlos Cordon-Obras, et al.
Journal of Medicinal Chemistry|September 20, 2025
Optimization of Physicochemical Properties and ADME for 2,4-Substituted 1<i>H</i>-Pyrrolo[2,3<i>b</i>]pyridines Inhibitors of Trypanosome ProliferationKelly A Bachovchin, Rosario Díaz, Gloria Ceballos-Perez, et al.
Journal of Medicinal Chemistry|June 22, 2021
Lead Optimization of 3,5-Disubstituted-7-Azaindoles for the Treatment of Human African TrypanosomiasisDana M Klug, Eftychia M Mavrogiannaki, Katherine C Forbes, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Scaffold and Parasite Hopping: Discovery of New Protozoal Proliferation InhibitorsBaljinder Singh, Jean A Bernatchez, Laura-Isobel McCall, et al.
RSC Medicinal Chemistry|January 22, 2021
Structure-property studies of an imidazoquinoline chemotype with antitrypanosomal activityDana M Klug, Rosario Diaz-Gonzalez, Travis J DeLano, et al.
Pageof 8